GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Debt-to-Revenue

Atomo Diagnostics (ASX:AT1) Debt-to-Revenue : 0.05 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Atomo Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.17 Mil. Atomo Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.03 Mil. Atomo Diagnostics's annualized Revenue for the quarter that ended in Dec. 2024 was A$3.78 Mil. Atomo Diagnostics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.05.


Atomo Diagnostics Debt-to-Revenue Historical Data

The historical data trend for Atomo Diagnostics's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics Debt-to-Revenue Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Debt-to-Revenue
0.03 0.01 0.03 0.10 0.04

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.10 0.11 0.04 0.03 0.05

Competitive Comparison of Atomo Diagnostics's Debt-to-Revenue

For the Medical Devices subindustry, Atomo Diagnostics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atomo Diagnostics's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's Debt-to-Revenue falls into.



Atomo Diagnostics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Atomo Diagnostics's Debt-to-Revenue for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.085 + 0.057) / 4.087
=0.03

Atomo Diagnostics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.174 + 0.025) / 3.784
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2024) Revenue data.


Atomo Diagnostics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Atomo Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines